360 High-Risk Vulnerability Immunization Tool V2.0 vs ThreatLocker Application Allowlisting: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

ThreatLocker Application Allowlisting: Application allowlisting that blocks unauthorized software by default. built by threatlocker. Core capabilities include Deny-by-default application control, Learning Mode for automatic application cataloging, User access request and approval workflow..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. ThreatLocker Application Allowlisting differentiates with Deny-by-default application control, Learning Mode for automatic application cataloging, User access request and approval workflow.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). ThreatLocker Application Allowlisting is developed by threatlocker. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and ThreatLocker Application Allowlisting serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.